Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination

Research output: Contribution to journalJournal articleResearchpeer-review

Standard

Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination. / Skorstengaard, Malene; Thamsborg, Lise Holst; Lynge, Elsebeth.

In: Vaccine, Vol. 35, No. 43, 13.10.2017, p. 5939-5945.

Research output: Contribution to journalJournal articleResearchpeer-review

Harvard

Skorstengaard, M, Thamsborg, LH & Lynge, E 2017, 'Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination', Vaccine, vol. 35, no. 43, pp. 5939-5945. https://doi.org/10.1016/j.vaccine.2017.08.062

APA

Skorstengaard, M., Thamsborg, L. H., & Lynge, E. (2017). Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination. Vaccine, 35(43), 5939-5945. https://doi.org/10.1016/j.vaccine.2017.08.062

Vancouver

Skorstengaard M, Thamsborg LH, Lynge E. Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination. Vaccine. 2017 Oct 13;35(43):5939-5945. https://doi.org/10.1016/j.vaccine.2017.08.062

Author

Skorstengaard, Malene ; Thamsborg, Lise Holst ; Lynge, Elsebeth. / Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination. In: Vaccine. 2017 ; Vol. 35, No. 43. pp. 5939-5945.

Bibtex

@article{ab0799fcf4e24a60b22c298941f4b1a7,
title = "Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination",
abstract = "Background: Denmark is one of the countries where Human papillomavirus (HPV)-vaccination at present includes only girls. However, the burden of HPV-related cancer in men is increasing, which would argue for gender-neutral vaccination. The aim of this study was to examine the burden of HPV-caused cancers in women and men, and to evaluate the potential of HPV-vaccination in cancer control.Methods: Data were retrieved from the literature on population prevalence of high risk (HR) HPV, on HR HPV-prevalence and genotypes in HPV-related cancers, and on number of cytology samples in cervical screening. Data on annual biopsies and conisations were retrieved from the Danish National Health Service Register and the Danish National Patient Register. Incidences of HPV-related cancers in Denmark were extracted from NORDCAN. Number of HPV-caused cancers was calculated from number of HPV-related cancers and the proportion known to be caused by high-risk (HR) HPV.Results: In cross-sectional surveys in Denmark, one fifth of women and almost one third of men were found to be positive for HR HPV. Per year, 548 HPV-caused cancer cases were diagnosed in women and 234 in men, and twice as many cancers in women as in men were preventable with HPV vaccination. However, including screening prevented cervical cancers, the burden of cancers caused by HPV-infection would be 1300–2000 in women as compared to 234 in men.Conclusion: Taking screening prevented cervical cancers into account, the cancer control potential of HPV-vaccination is considerably higher in women than in men. HPV-vaccination could reduce the burden of screening on women and on health care resources.",
keywords = "Human papillomavirus (HPV), HPV-vaccination, Cervical screening, Cervical cancer, Cervical intraepithelial neoplasia (CIN)",
author = "Malene Skorstengaard and Thamsborg, {Lise Holst} and Elsebeth Lynge",
year = "2017",
month = "10",
day = "13",
doi = "10.1016/j.vaccine.2017.08.062",
language = "English",
volume = "35",
pages = "5939--5945",
journal = "Vaccine",
issn = "0264-410X",
publisher = "Elsevier",
number = "43",

}

RIS

TY - JOUR

T1 - Burden of HPV-caused cancers in Denmark and the potential effect of HPV-vaccination

AU - Skorstengaard, Malene

AU - Thamsborg, Lise Holst

AU - Lynge, Elsebeth

PY - 2017/10/13

Y1 - 2017/10/13

N2 - Background: Denmark is one of the countries where Human papillomavirus (HPV)-vaccination at present includes only girls. However, the burden of HPV-related cancer in men is increasing, which would argue for gender-neutral vaccination. The aim of this study was to examine the burden of HPV-caused cancers in women and men, and to evaluate the potential of HPV-vaccination in cancer control.Methods: Data were retrieved from the literature on population prevalence of high risk (HR) HPV, on HR HPV-prevalence and genotypes in HPV-related cancers, and on number of cytology samples in cervical screening. Data on annual biopsies and conisations were retrieved from the Danish National Health Service Register and the Danish National Patient Register. Incidences of HPV-related cancers in Denmark were extracted from NORDCAN. Number of HPV-caused cancers was calculated from number of HPV-related cancers and the proportion known to be caused by high-risk (HR) HPV.Results: In cross-sectional surveys in Denmark, one fifth of women and almost one third of men were found to be positive for HR HPV. Per year, 548 HPV-caused cancer cases were diagnosed in women and 234 in men, and twice as many cancers in women as in men were preventable with HPV vaccination. However, including screening prevented cervical cancers, the burden of cancers caused by HPV-infection would be 1300–2000 in women as compared to 234 in men.Conclusion: Taking screening prevented cervical cancers into account, the cancer control potential of HPV-vaccination is considerably higher in women than in men. HPV-vaccination could reduce the burden of screening on women and on health care resources.

AB - Background: Denmark is one of the countries where Human papillomavirus (HPV)-vaccination at present includes only girls. However, the burden of HPV-related cancer in men is increasing, which would argue for gender-neutral vaccination. The aim of this study was to examine the burden of HPV-caused cancers in women and men, and to evaluate the potential of HPV-vaccination in cancer control.Methods: Data were retrieved from the literature on population prevalence of high risk (HR) HPV, on HR HPV-prevalence and genotypes in HPV-related cancers, and on number of cytology samples in cervical screening. Data on annual biopsies and conisations were retrieved from the Danish National Health Service Register and the Danish National Patient Register. Incidences of HPV-related cancers in Denmark were extracted from NORDCAN. Number of HPV-caused cancers was calculated from number of HPV-related cancers and the proportion known to be caused by high-risk (HR) HPV.Results: In cross-sectional surveys in Denmark, one fifth of women and almost one third of men were found to be positive for HR HPV. Per year, 548 HPV-caused cancer cases were diagnosed in women and 234 in men, and twice as many cancers in women as in men were preventable with HPV vaccination. However, including screening prevented cervical cancers, the burden of cancers caused by HPV-infection would be 1300–2000 in women as compared to 234 in men.Conclusion: Taking screening prevented cervical cancers into account, the cancer control potential of HPV-vaccination is considerably higher in women than in men. HPV-vaccination could reduce the burden of screening on women and on health care resources.

KW - Human papillomavirus (HPV)

KW - HPV-vaccination

KW - Cervical screening

KW - Cervical cancer

KW - Cervical intraepithelial neoplasia (CIN)

U2 - 10.1016/j.vaccine.2017.08.062

DO - 10.1016/j.vaccine.2017.08.062

M3 - Journal article

VL - 35

SP - 5939

EP - 5945

JO - Vaccine

JF - Vaccine

SN - 0264-410X

IS - 43

ER -

ID: 185230505